EGFR and non-small cell lung carcinoma: In non-small-cell lung cancer, upregulation of LINC00665 confers gefitinib resistance by increasing EGFR expression and activating downstream AKT signaling, thus antagonizes gefitinib induced cell apoptosis and proliferation arrest11.